PATENT CLAIM ANALYSIS

Application Number: 15865631
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "070000"]

Abstract:
Treatment of patients with the 2S,4R ketoconazole enantiomer or its pharmaceutically acceptable salts, and solvates is useful for reducing systemic inflammation and cholesterol levels and improving glycemic control.

Claim (Index 8):
The method of  claim 1 , wherein the therapeutically effective amount of the 2S,4R ketoconazole enantiomer is a daily dose of 400 mg.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 86.0
- Lexical Diversity: 1.07143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12443531', '15507669', '11326201', '12536295', '13432470']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7364204432809563
- 35 USC 102 Novelty (BERT): 0.62787459490167
- Combined Prediction Score: 0.7255658584430277
- Mean Citation Score: 313.81365
- Max Citation Score: 623.3229
- Similarity Product: 494.76098402093055

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test